Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hot Spot TERT Promoter Mutations Are Rare in Sporadic Pancreatic Neuroendocrine Neoplasms and Associated with Telomere Length and Epigenetic Expression Patterns.
Posch A, Hofer-Zeni S, Klieser E, Primavesi F, Naderlinger E, Brandstetter A, Filipits M, Urbas R, Swiercynski S, Jäger T, Winkelmann P, Kiesslich T, Lu L, Neureiter D, Stättner S, Holzmann K. Posch A, et al. Among authors: brandstetter a. Cancers (Basel). 2020 Jun 19;12(6):1625. doi: 10.3390/cancers12061625. Cancers (Basel). 2020. PMID: 32575418 Free PMC article.
CDK10 is not a target for aberrant DNA methylation in breast cancer.
Heller G, Ziegler B, Brandstetter A, Novak S, Rudas M, Hennig G, Gehrmann M, Acht T, Zöchbauer-Müller S, Filipits M. Heller G, et al. Among authors: brandstetter a. Anticancer Res. 2009 Oct;29(10):3939-44. Anticancer Res. 2009. PMID: 19846932 Free article.
Simultaneous blockade of the epidermal growth factor receptor/mammalian target of rapamycin pathway by epidermal growth factor receptor inhibitors and rapamycin results in reduced cell growth and survival in biliary tract cancer cells.
Herberger B, Berger W, Puhalla H, Schmid K, Novak S, Brandstetter A, Pirker C, Gruenberger T, Filipits M. Herberger B, et al. Among authors: brandstetter a. Mol Cancer Ther. 2009 Jun;8(6):1547-56. doi: 10.1158/1535-7163.MCT-09-0003. Epub 2009 Jun 9. Mol Cancer Ther. 2009. PMID: 19509244
Low protein expression of MET in ER-positive and HER2-positive breast cancer.
Zagouri F, Brandstetter A, Moussiolis D, Chrysikos D, Dimitrakakis C, Tsigginou A, Marinopoulos S, Zografos GC, Sergentanis TN, Dimopoulos MA, Filipits M. Zagouri F, et al. Among authors: brandstetter a. Anticancer Res. 2014 Mar;34(3):1227-31. Anticancer Res. 2014. PMID: 24596364
Expression of ARs in triple negative breast cancer tumors: a potential prognostic factor?
Giannos A, Filipits M, Zagouri F, Brandstetter A, Tsigginou A, Sotiropoulou M, Papaspyrou I, Sergentanis TN, Psaltopoulou T, Rodolakis A, Antsaklis A, Dimopoulos MA, Dimitrakakis C. Giannos A, et al. Among authors: brandstetter a. Onco Targets Ther. 2015 Jul 23;8:1843-7. doi: 10.2147/OTT.S78254. eCollection 2015. Onco Targets Ther. 2015. PMID: 26229492 Free PMC article.
Impact of epidermal growth factor receptor, mesenchymal-epithelial transition factor, and insulin-like growth factor receptor 1 expression on survival of patients with oral and oropharyngeal cancer.
Perisanidis C, Wrba F, Brandstetter A, Kornek G, Mitchell D, Seemann R, Selzer E, Ewers R, Filipits M. Perisanidis C, et al. Among authors: brandstetter a. Br J Oral Maxillofac Surg. 2013 Apr;51(3):234-40. doi: 10.1016/j.bjoms.2012.06.009. Epub 2012 Aug 11. Br J Oral Maxillofac Surg. 2013. PMID: 22889668
30 results